MedPath
FDA Approval

MKO Melt Dose Pack

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Imprimis NJOF, LLC
DUNS: 080431967
Effective Date
March 4, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Midazolam(3 mg in 1 1)
Ketamine(25 mg in 1 1)
Ondansetron(2 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Imprimis NJOF, LLC

080431967

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MKO Melt Dose Pack

Product Details

NDC Product Code
71384-410
Route of Administration
SUBLINGUAL
Effective Date
March 4, 2019
MidazolamActive
Code: R60L0SM5BCClass: ACTIBQuantity: 3 mg in 1 1
KetamineActive
Code: O18YUO0I83Class: ACTIMQuantity: 25 mg in 1 1
Code: 2999F27MADClass: ACTIMQuantity: 2 mg in 1 1

Drug Labeling Information

Complete FDA-approved labeling information including indications, dosage, warnings, contraindications, and other essential prescribing details.

STORAGE AND HANDLING SECTION

Storage and Handling

Store at 20° to 25° C (68° to 77° F)


© Copyright 2025. All Rights Reserved by MedPath